Synthesis and antitumor activity of mechercharmycin A analogues

Journal of Medicinal Chemistry

Volumn 51, Issue 18, 2008, Pages 5722-5730

  Hernández, Delia ^a   Altuna, Marta ^a   Cuevas, Carmen ^b   Aligué, Rosa ^a   Albericio, Fernando ^a   Álvarez, Mercedes ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b PHARMAMAR S A   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IB 01211; MECHERCHARMYCIN A; OXAZOLE DERIVATIVE; PEPTIDE DERIVATIVE; THIOPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE REGULATION; CELL STRAIN HT29; DRUG CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES, CYCLIC; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THIAZOLES;

EID: 52449105717     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800513w     Document Type: Article

References (24)

1. Yeung, K.; Paterson, I. Actin-binding marine macrolides: total synthesis and biological importance. Angew. Chem., Int. Ed. 2002, 41, 4632-4653.
2. Recent revisions about the chemistry and properties can be found in the following: (a) Roy, R. S.; Gehring, A. M.; Milne, J. C.; Belshaw, P. J.; Walsh, C. T. Thiazole and oxazole peptides: biosynthesis and molecular machinery. Nat. Prod. Rep. 1999, 16, 249-263.
3. (b) Yeh, V. S. C. Recent advances in the total syntheses of oxazole-containing natural products. Tetrahedron 2004, 60, 11995-12042.
4. (c) Riego, E.; Hernández, D.; Albericio, F.; Álvarez, M. Directly linked polyazoles: important moieties in natural products. Synthesis 2005, 1907-1922.
5. (d) Jin, Z. Imidazole, oxazole and thiazole alkaloids. Nat. Prod. Rep. 2006, 23, 464-496.
6. Nagatsu, A.; Kajitani, H.; Sakakibara, J. Muscoride A: a new oxazole peptide alkaloid from freshwater cyanobacterium Nostoc muscorum. Tetrahedron Lett. 1995, 36, 4097-4100.
7. Kehraus, S.; König, G. M.; Wright, A. D. Leucamide A: a new cytotoxic heptapeptide from the australian sponge Leucetta microraphis. J. Org. Chem. 2002, 67, 4989-4992.
8. (a) Shin-ya, K.; Wierzba, K.; Matsuo, K.; Ohtani, T.; Yamada, Y.; Furihata, K.; Hayakawa, Y.; Seto, H. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J. Am. Chem. Soc. 2001, 123, 1262-1263.
9. (b) Doi, T.; Yoshida, M.; Shin-ya, K.; Takahashi, T. Total synthesis of (R)-telomestatin. Org. Lett. 2006, 8, 4165-4167.
10. Lindquist, N.; Fenical, W.; Van Duyne, G. D.; Clardy, J. Isolation and structure determination of diazonamides A and B, unusual cytotoxic metabolites from the marine ascidian Diazona chinensis. J. Am. Chem. Soc. 1991, 113, 2303-2304.
11. (a) IB-01211 was isolated from the marine microorganism strain ES7-008: Romero, F.; Malet, L.; Cañedo, L, M.; Cuevas, C.; Reyes, J. New Cytotoxic Depsipeptides. WO 2005/000880 A2, 2005.
12. (b) The same structure was proposed for mechercharmycin A, isolated from a marine-derived Thermoactinomices sp: Kanoh, K.; Matsuo.Y.; Adachi, K.; Imagawa, H.; Nishizawa, M.; Shizuri, Y. Mechercharmycins A and B, cytotoxic substances from marine-derived Thermoactinomyces sp. YM3-251. J. Antibiot. 2005, 58, 289-292.
13. (a) Hernández, D.; Vilar, G.; Riego, E.; Cañedo, L. M.; Cuevas, C.; Albericio, F.; Álvarez, M. Synthesis of IB-01211, a cyclic peptide containing 2,4-concatenated thia- and oxazoles, via Hantzsch macrocyclization. Org. Lett. 2007, 9, 809-811.
14. (b) Hernández, D.; Riego, E.; Francesch, A.; Cuevas, C.; Albericio, F.; Álvarez, M. Preparation of penta-azole containing cyclopeptides: challenges in macrocyclization. Tetrahedron 2007, 63, 9862-9870.
15. Sohda, K-y.; Nagai, K.; Yamori, T.; Suzuki, K-i.; Tanaka, A. YM-216391, a novel cytotoxic cyclic peptide from Streptomyces nobilis. J. Antibiot. 2005, 58, 27-31.
16. Hydrolysis of the methyl ester was performed using LiOH in aqueous THF and MeOH as detailed in the Experimental Section.
17. These conditions for the thiazole Hantzsch synthesis afforded an easier purification of crude material than conditions obtained before; see ref 8.
18. 2.
19. 50 for YM-216391 in HeLa S3 is 14 nM: Sanada, K.; Takeba-yashi, Y.; Nagai, K.; Hiramoto, M. New antitumor compound. Jpn. Kokai Tokkyo Koho 1999, JP11180997-A; Chem. Abstr. 1999, 131, 101307j.
20. Hernández, D.; Riego, E.; Albericio, F.; Álvarez, M. Synthesis of natural product derivatives containing 2,4-concatenated oxazoles. Eur. J. Org. Chem. 2008, 3389-3396.
21. Ekert, P. G.; Silke, J.; Vaux, D. L. Caspase inhibitors synthesis of natural product derivatives containing 2,4-concatenated oxazoles. Cell Death Differ. 1999, 6, 1081-1086.
22. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Waren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
23. Boyd, M. R.; Pauli, K. D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 1995, 34, 91-104.
24. Rotonda, J.; Nicholson, D. W.; Fazil, K. M.; Gallart, Y. G.; Labelle, M.; Peterson, E. P.; Rasper, D. M.; Ruel, R.; Vaillancourt, J. P.; Thornberry, N. A.; Becker, J. W. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol. 1996, 3, 619-625.